Nanjing Well Pharmaceutical GroupLtd 配当金
配当金 基準チェック /36
Nanjing Well Pharmaceutical GroupLtd is a dividend paying company with a current yield of 1.2% that is well covered by earnings.
主要情報
1.2%
配当利回り
0.3%
バイバック利回り
| 総株主利回り | 1.5% |
| 将来の配当利回り | n/a |
| 配当成長 | -0.6% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | CN¥0.300 |
| 配当性向 | 28% |
最近の配当金アップデート
Recent updates
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality
Aug 26
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Upcoming Dividend Will Be Larger Than Last Year's
Jun 07Little Excitement Around Nanjing Well Pharmaceutical Group Co.,Ltd.'s (SHSE:603351) Earnings
Jun 06決済の安定と成長
配当データの取得
安定した配当: Whilst dividend payments have been stable, 603351 has been paying a dividend for less than 10 years.
増加する配当: 603351 has only been paying a dividend for 5 years, and since then payments have fallen.
配当利回り対市場
| Nanjing Well Pharmaceutical GroupLtd 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (603351) | 1.2% |
| 市場下位25% (CN) | 0.6% |
| 市場トップ25% (CN) | 2.2% |
| 業界平均 (Chemicals) | 1.8% |
| アナリスト予想 (603351) (最長3年) | n/a |
注目すべき配当: 603351's dividend (1.2%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
高配当: 603351's dividend (1.2%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
株主への利益配当
収益カバレッジ: With its reasonably low payout ratio (27.8%), 603351's dividend payments are well covered by earnings.
株主配当金
キャッシュフローカバレッジ: With its reasonably low cash payout ratio (25%), 603351's dividend payments are well covered by cash flows.